Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S44121 dose-ranging versus placebo in chronic heart failure without beta-blocker therapy
2009-011559-38Phase 2Completed
- Sponsor
- Servier
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of S44121 in chronic heart failure (CHF) and left ventricular dysfunction (5 arms), sponsored by Servier. Primary endpoints: Echocardiographic parameters and NT-proBNP levels. Started Jan 2010; status: completed.
02
Drugs
S44121
03
Conditions
chronic heart failure (CHF)left ventricular dysfunction
Beyond the preview
Go deeper on 2009-011559-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011559-38.